GRCE

Grace Therapeutics, Inc

3.330

-0.740-18.18%

Opening15:37 04/07 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE4.010/4.070

TODAY RANGE2.500-4.210

VOL5.49M

MARKET CAP51.53M

52 WEEK RANGE1.750-5.18

AVG VOL (3M)304.44K

% TURNOVER35.49%

TURNOVER--

P/E (TTM)-9.2320

% RANGE42.00%

EPS(TTM)-0.3607

P/E(FORWARD)-0.5365

P/B0.7941

BVPS4.194

DIVIDEND--

P/S33.92

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP35.35M

SHARES OUTSTANDING15.47M

NEXT EARNINGS06/26-07/02

FREE FLOAT10.62M

LOT SIZE1

EX-DATE07/10/2023

News

Press Releases

Financial Reports

Profile

Reuters·03/19 12:01
Grace Therapeutics to present GTx-104 aSAH data at two medical conferences
Reuters·02/13 17:42
Grace Therapeutics Showcases Phase 3 Success for IV Nimodipine in aSAH Treatment
TipRanks·02/12 17:30
Analysts Are Bullish on Top Healthcare Stocks: Grace Therapeutics (GRCE), Alto Neuroscience, Inc. (ANRO)
Seeking Alpha·02/12 13:14
Grace Therapeutics GAAP EPS of -$0.14 beats by $0.14
TipRanks·02/12 13:08
Grace Therapeutics reports Q3 EPS (14c) vs (36c) last year
Reuters·02/12 13:00
GRACE THERAPEUTICS ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS, PROVIDES BUSINESS UPDATE
Dow Jones·02/12 13:00
Press Release: Grace Therapeutics Announces Third -3-
Dow Jones·02/12 13:00
Press Release: Grace Therapeutics Announces Third Quarter 2026 Financial Results, Provides Business Update
Reuters·02/12 12:32
Grace Therapeutics posts Q3 R&D expenses of USD 0.46 million
TipRanks·01/22 13:36
Ten new option listings and two option delistings on January 22nd
TipRanks·01/12 22:32
Grace Therapeutics Enhances Executive Severance and Change‑in‑Control Terms
Reuters·01/12 22:01
Grace Therapeutics Updates Executive Severance and Change-in-Control Compensation Terms
Reuters·11/30/2025 21:55
Grace Therapeutics Unveils Data on Novel IV Nimodipine for Subarachnoid Hemorrhage
Reuters·11/17/2025 13:03
Grace Therapeutics to Participate in Craig-Hallum Alpha Select Conference
TipRanks·11/14/2025 04:26
Grace Therapeutics Reports Q2 2026 Results and FDA Progress

Same Industry

Name/Symbol

Change%

Price

GRCE

Regeneron Pharmaceuticals

REGN

-1.98%

761.85

GridAI Tech

GRDX

-3.63%

2.390

BNTX

United Therapeutics Corp.

UTHR

-0.96%

564.81

VRTX

Siga Technologie

SIGA

-1.20%

4.545

MRNA

Charles Riv Labs Intl Inc

CRL

-3.26%

168.22

MEDP

Talphera Inc

TLPH

-7.12%

0.7223

ICLR

CBPO

IQV

MOLN

Arcturus Therape

ARCT

+2.29%

8.03

Gilead Sciences Inc

GILD

+0.30%

140.13

PRAH

Incyte Corp

INCY

-1.12%

94.86

APVO

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.